Paul Peter Tak, MD, PhD served as Professor of Medicine and Chair of the Department of Clinical Immunology and Rheumatology at the Academic Medical Centre/University of Amsterdam (AMC). At GlaxoSmithKline (GSK) he served as Senior Vice President, Chief Immunology Officer, and Global Development Leader, and oversaw the creation of a portfolio of new medicines for immune-mediated inflammatory diseases, cancer and infectious diseases. He has been CEO of Tempero Pharmaceuticals and Kintai Therapeutics, a Flagship Pioneering company, and served on the Board of multiple biotech companies.